News

US President Donald Trump has agreed to extend negotiations with the European Union over proposed trade tariffs, pushing back ...
Norwest intends to allocate the raised funds towards reviewing mining options at its Bulgera project and recommencing drill ...
Concurrently, OncoSil is conducting a placement to institutional and sophisticated investors, targeting $6.7 million. The placement involves issuing up to 2,233,333,333 new shares across two tranches, ...
New Age Exploration (NAE) has announced promising assay results from its maiden Reverse Circulation (RC) drill program at the Wagyu Gold Project in the Pilbara region of Western Australia. The ...
China represents the world’s second-largest pharmaceutical market, with its antibiotic market valued at approximately US$4.09 billion and projected to grow at a CAGR of 5.7% from 2025 to 2030. Recce ...
CEO Marc Voigt delivers an update on the company’s recent clinical milestones, highlighting significant progress across multiple cancer indications. The focus of the presentation is the company’s ...
Efti combination demonstrates significant tumor response in sarcoma trial, exceeding expectations without chemotherapy.
Wall Street finished lower on Friday as investors digested renewed trade rhetoric from President Donald Trump and a direct threat to Apple. The Dow Jones Industrial Average dropped 256 points to ...
Here’s some of the companies that made the news this week. Mayne Pharma disputes Cosette’s claims of material adverse change amid takeover uncertainty Mayne Pharma (ASX:MYX) has rejected ...
President Donald Trump on Friday signed a sweeping package of executive orders aimed at jump-starting the U.S. nuclear industry, overhauling federal regulations, and accelerating the deployment of ...
President Donald Trump reignited global trade tensions on Friday by threatening sweeping new tariffs on the European Union and Apple, triggering a broad selloff in markets and raising uncertainty ...
Yowie Group Ltd has escalated its takeover bid for Keybridge Capital Limited (ASX: KBC) by applying to the Takeovers Panel, alleging that Keybridge is acting to frustrate its offer. The ...